SlideShare a Scribd company logo
Orodispersible liquisolid compacts
Presented by:
Pranali .M.Palandurakar
University department of Pharmaceutical
sciences R.T.M.N.U
INTRODUCTION
 Liquisolid technique is a new and promising method which is used to
enhance dissolution rate of poorly water-soluble drugs.
 This new technique may be applied to formulate liquid medications
into powders suitable for tableting or encapsulation.
 Orodispersible formulations rapidly disintegrate and/or dissolve to
release the drug as soon as they come in contact with saliva, thus
without the need for water during administration .
 Thus, it improves the patient’s compliance and highly attractive for
pediatric and geriatric patients .
LIQUISOLID SYSTEM:
 This technique is applied to incorporate water insoluble drugs into
rapid release solid dosage forms.
COMPONENTS OF LIQUISOLID SYSTEMS
 Carrier Materials: These are compression-enhancing, relatively large,
preferably porous particles possessing a sufficient absorption property
which contributes in liquid absorption.
Ex-Various grades of cellulose, starch, lactose, sorbitol, Avicel PH 102
and 200, Eudragit RL and RS, amorphous cellulose etc.
 Coating Materials: These are flow-enhancing, very fine (10 to 5,000 nm in
diameter), highly adsorptive coating particles contributes in covering the
wet carrier particles and displaying a dry-looking powder by adsorbing any
excess liquid.
Ex-Silica of various grades like Cab-O-Sil M5, Aerosil 200, Syloid 244FP etc.
 Non-Volatile Solvents: Inert, high boiling point, preferably water-
miscible and not highly viscous organic solvent systems.
Ex-Polyethylene glycol 200 and 400, glycerin, polysorbate 80 and propylene
glycol, polysorbates, glycerin, N, N- dimethylacetamide, fixed oils, etc.
 Disintegrants: Superdisintegrants increases the rate of drug release,
water solubility and wettability of liquisolid granules.
Ex-Sodium starch glycolate and crosspovidone and croscarmellose sodium are
used.
MECHANISMS OF ENHANCEMENT OF
DRUG RELEASE
 Increased drug surface area
 In liquisolid system the surface area of drug available for drug release is much
greater than that of drug particles within directly compressed tablets because
the drug present in the liquisolid system is completely dissolved in the liquid
vehicle and present in the powder substrate still in a solubilized, molecularly
dispersed state
 In the liquid solid formulation, the release rate of the drug is directly
proportional to the fraction of the molecularly dispersed drug (FM).
FM= Sd/Cd
Where,
FM-fraction of the molecularly dispersed drug .
Sd- drug solubility
Cd- Actual drug concentration
 Increased aqueous solubility of the drug
In addition to the first mechanism of drug release enhancement, it is expected
that the solubility of the drug might be increased with liquisolid
Increased wettability
The non-volatile solvent present in the liquisolid system provides wetting of drug
particles by decreasing interfacial tension between tablet surface and dissolution
medium so the contact angle of liquisolid system is lower when compared to the
conventional formulation thus improved wettability .
APPLICATIONS OF LIQUISOLID
 Liquisolid compact technology is a powerful tool to improve bioavailability of
water insoluble drugs. Several water insoluble drugs on dissolving in different
nonvolatile solvents have been formulated into liquisolid compacts.
 Different drugs can be incorporated into liquisolid compacts.
 Rapid release rates.
 Used for water insoluble solid drugs or liquid lipophilic drugs.
 Sustained release of drugs.
 Solubility and dissolution improvement.
 Flowability and compressibility.
 Designing of controlled release tablets.
 Bioavailability enhancement.
 Application in probiotics.
 Improvement of drug photostability.
ORODISPERSIBLE TABLETS
 Center for Drug Evaluation and Research (CDER) defines ODT in the
‘Orange Book’ as “a solid dosage form containing medicinal
substances, which disintegrates rapidly, usually within a matter of
seconds, when placed upon the tongue”.
DRUG SELECTION CRITERIA FOR
ODTs
The drug to be formulate as orodispersible liquisolids must have following criterias:
 Drug should able to saturate the oral mucosa,
 At least moderately non-ionized at oral cavity pH,
 Ability to diffuse and partition into the epithelium of upper GIT,
 Small to moderate molecular weight,
 Low dose drugs mostly less than 50 mg,
 Good stability in saliva and water,
ADVANTAGES OF ODTs
 Administration to the patients who cannot swallow, such as the elderly, stroke
victims, bedridden patients, patients affected by renal failure & patients who
refuse to swallow such as paediatric, geriatric & psychiatric patients gives
better patient compliance
 Rapid drug therapy.
 Increased bioavailability/rapid absorption through pregastric absorption of
drugs from mouth, pharynx & oesophagus as saliva passes down.
 The risk of chocking during oral administration of conventional formulations
due to physical obstruction is avoided, thus providing improved safety.
 Good mouth feel property helps to change the perception of medication as
bitter pill particularly in paediatric patients
METHOD OF PREPARATION OF ORODISPERSIBLE
LIQUISOLID SYSTEM
Solid drugs
+
Non-volatile
solvent
Drug in solution
or suspension
Liquid drugs
Liquid medication
Wet particles
Liquisolid system
Final formulation
Tabletting or encapsulation
Carrier
material
Coating
material
Addition of
other
excipients
or
CHARACTERIZATION OF
ORODISPERSIBLE LIQUISOLID:
a) Solubility studies: Solubility studies are carried out by preparing saturated
solutions of drug in non-volatile solvent and analyzing them
spectrophotometrically. Saturated solutions are prepared by adding excess of
drug to non volatile solvent and shaking them on shaker for specific time
period under constant vibration. After this, the solutions are filtered and
analyzed spectrophotometrically
b) Determination of angle of slide: Angle of slide is used as a measure of the
flow properties of powders. Determination of angle of slide is done by
weighing the required amount of carrier material and placed at one end of a
metal plate with a polished surface. The end is gradually raised till the plate
becomes angular to the horizontal at which powder is about to slide. This
angle is known as angle of slide. Angle of 33º is regarded as optimum
c) Determination of flowable liquid retention potential (Φ-value): The
term "flowable liquid- retention potential" (Φ-value) of a powder material
describes its ability to retain a specific amount of liquid while
maintaining good flow properties. The Φ-value is defined as the
maximum weight of liquid that can be retained per unit weight of the
powder material in order to produce an acceptably flowing liquid/powder
admixture. The Φ values are calculated according to equation
Φ value = weight of liquid / weight of solid
d) Calculation of liquid load factor (Lf): Different concentrations of non-
volatile solvents are taken and the drug is dissolved. Such liquid
medication is added to the carrier-coating material admixture and
blended. Drug loading factors are determined and used for calculating
the amounts of carrier and coating materials in each formulation.
Lf = WLM/ WCM
Where:
WLM is weight of liquid medication
WCM is weight of carrier material.
e) Liquisolid compressibility test (LSC): The Liquisolid compressibility test
is used to determine Φ values and involves steps such as preparing
carrier coating material admixture systems, preparing several uniform
liquid or powder admixtures, compressing each liquid or powder
admixtures to tablets, assessing the average hardness, determination of
the average liquid content of crushed tablets, as well as determining
plasticity, sponge index and Φ value and Lf .
Orodispersible liquisolid compacts

More Related Content

What's hot

Oral & dissolution controlled release system
Oral & dissolution controlled release systemOral & dissolution controlled release system
Oral & dissolution controlled release system
Sonam Gandhi
 
Oral sustained and controlled release dosage forms
Oral sustained and controlled release dosage forms Oral sustained and controlled release dosage forms
Oral sustained and controlled release dosage forms
Dr Gajanan Sanap
 
buccal drug delivery system
buccal drug delivery systembuccal drug delivery system
buccal drug delivery system
rasikawalunj
 
NIOSOME, ITS PREPARATION AND EVALUATION
NIOSOME, ITS PREPARATION AND EVALUATIONNIOSOME, ITS PREPARATION AND EVALUATION
NIOSOME, ITS PREPARATION AND EVALUATION
MUSTAFIZUR RAHMAN
 
Compression and compaction
Compression and compactionCompression and compaction
Compression and compaction
Sagar Savale
 
Controlled Release Drug Delivery Systems - Types, Methods and Applications
Controlled Release Drug Delivery Systems - Types, Methods and ApplicationsControlled Release Drug Delivery Systems - Types, Methods and Applications
Controlled Release Drug Delivery Systems - Types, Methods and Applications
Suraj Choudhary
 
Physicochemical Properties effect on Absorption of Drugs
Physicochemical Properties effect on Absorption of DrugsPhysicochemical Properties effect on Absorption of Drugs
Physicochemical Properties effect on Absorption of Drugs
Suraj Choudhary
 
Dissolution
DissolutionDissolution
Implantable Drug Delivery System
Implantable Drug Delivery SystemImplantable Drug Delivery System
Implantable Drug Delivery System
Sourav Kar
 
Osmotic drug delivery system
Osmotic drug delivery systemOsmotic drug delivery system
Osmotic drug delivery system
doll969
 
Controlled Release Oral Drug Delivery System
Controlled Release Oral Drug Delivery SystemControlled Release Oral Drug Delivery System
Controlled Release Oral Drug Delivery System
Ravishankar University, Raipur
 
Feedback regulated drug delivery system
Feedback regulated drug delivery systemFeedback regulated drug delivery system
Feedback regulated drug delivery system
Surbhi Narang
 
FLOATING DRUG DELIVERY SYSTEM
FLOATING DRUG DELIVERY SYSTEMFLOATING DRUG DELIVERY SYSTEM
FLOATING DRUG DELIVERY SYSTEM
Ihtesham Rehman
 
Implant : Challenging Drug Delivery System
Implant : Challenging Drug Delivery SystemImplant : Challenging Drug Delivery System
Implant : Challenging Drug Delivery System
biniyapatel
 
Transdermal Drug Delivery System (TDDS)
Transdermal Drug Delivery System (TDDS)Transdermal Drug Delivery System (TDDS)
Transdermal Drug Delivery System (TDDS)
PRABU12345678
 
Dry Powder Inhaler ppt.
Dry Powder Inhaler ppt.Dry Powder Inhaler ppt.
Dry Powder Inhaler ppt.
Tejas Jagtap
 
Bioadhesive drug delivery system
Bioadhesive drug delivery systemBioadhesive drug delivery system
Bioadhesive drug delivery system
Dr. Shreeraj Shah
 
Ocular inserts
Ocular insertsOcular inserts
Ocular inserts
amina tariq
 
Dissolution
DissolutionDissolution
Dissolution
Shreeshail Tumbagi
 

What's hot (20)

Oral & dissolution controlled release system
Oral & dissolution controlled release systemOral & dissolution controlled release system
Oral & dissolution controlled release system
 
Oral sustained and controlled release dosage forms
Oral sustained and controlled release dosage forms Oral sustained and controlled release dosage forms
Oral sustained and controlled release dosage forms
 
buccal drug delivery system
buccal drug delivery systembuccal drug delivery system
buccal drug delivery system
 
NIOSOME, ITS PREPARATION AND EVALUATION
NIOSOME, ITS PREPARATION AND EVALUATIONNIOSOME, ITS PREPARATION AND EVALUATION
NIOSOME, ITS PREPARATION AND EVALUATION
 
Compression and compaction
Compression and compactionCompression and compaction
Compression and compaction
 
Controlled Release Drug Delivery Systems - Types, Methods and Applications
Controlled Release Drug Delivery Systems - Types, Methods and ApplicationsControlled Release Drug Delivery Systems - Types, Methods and Applications
Controlled Release Drug Delivery Systems - Types, Methods and Applications
 
Physicochemical Properties effect on Absorption of Drugs
Physicochemical Properties effect on Absorption of DrugsPhysicochemical Properties effect on Absorption of Drugs
Physicochemical Properties effect on Absorption of Drugs
 
Dissolution
DissolutionDissolution
Dissolution
 
Pilot plant liquid orals
Pilot plant liquid oralsPilot plant liquid orals
Pilot plant liquid orals
 
Implantable Drug Delivery System
Implantable Drug Delivery SystemImplantable Drug Delivery System
Implantable Drug Delivery System
 
Osmotic drug delivery system
Osmotic drug delivery systemOsmotic drug delivery system
Osmotic drug delivery system
 
Controlled Release Oral Drug Delivery System
Controlled Release Oral Drug Delivery SystemControlled Release Oral Drug Delivery System
Controlled Release Oral Drug Delivery System
 
Feedback regulated drug delivery system
Feedback regulated drug delivery systemFeedback regulated drug delivery system
Feedback regulated drug delivery system
 
FLOATING DRUG DELIVERY SYSTEM
FLOATING DRUG DELIVERY SYSTEMFLOATING DRUG DELIVERY SYSTEM
FLOATING DRUG DELIVERY SYSTEM
 
Implant : Challenging Drug Delivery System
Implant : Challenging Drug Delivery SystemImplant : Challenging Drug Delivery System
Implant : Challenging Drug Delivery System
 
Transdermal Drug Delivery System (TDDS)
Transdermal Drug Delivery System (TDDS)Transdermal Drug Delivery System (TDDS)
Transdermal Drug Delivery System (TDDS)
 
Dry Powder Inhaler ppt.
Dry Powder Inhaler ppt.Dry Powder Inhaler ppt.
Dry Powder Inhaler ppt.
 
Bioadhesive drug delivery system
Bioadhesive drug delivery systemBioadhesive drug delivery system
Bioadhesive drug delivery system
 
Ocular inserts
Ocular insertsOcular inserts
Ocular inserts
 
Dissolution
DissolutionDissolution
Dissolution
 

Similar to Orodispersible liquisolid compacts

Solid Dispersion - Solubility enhancing tool
Solid Dispersion - Solubility enhancing toolSolid Dispersion - Solubility enhancing tool
Solid Dispersion - Solubility enhancing tool
Suraj Choudhary
 
Formulation and Evaluation of Liquisolid Compacts of Carvedilol
Formulation and Evaluation of Liquisolid Compacts of CarvedilolFormulation and Evaluation of Liquisolid Compacts of Carvedilol
Formulation and Evaluation of Liquisolid Compacts of Carvedilol
IOSR Journals
 
Recent innovation in liquid dosage form 1by sachin
Recent innovation in liquid dosage form 1by sachinRecent innovation in liquid dosage form 1by sachin
Recent innovation in liquid dosage form 1by sachin
Sachin Prajapati
 
Liquisolid technology
Liquisolid technologyLiquisolid technology
Liquisolid technology
konatham teja kumar reddy
 
Pharmacokinetics mpharm
Pharmacokinetics mpharmPharmacokinetics mpharm
Pharmacokinetics mpharm
Chirudeep Chowdary
 
Controlled drug release
Controlled drug releaseControlled drug release
Controlled drug release
Chirag Goda
 
Factors affecting absorption
Factors affecting absorptionFactors affecting absorption
Factors affecting absorption
Malla Reddy College of Pharmacy
 
Factors affecting drug absorption
Factors affecting drug absorptionFactors affecting drug absorption
Factors affecting drug absorption
Venkidesh Rajagopal
 
Solubility enhancement technique
Solubility enhancement technique Solubility enhancement technique
Solubility enhancement technique
Gangadhar BM
 
Solubility & Method for determination of solubility
Solubility & Method for determination of solubility  Solubility & Method for determination of solubility
Solubility & Method for determination of solubility
Zulcaif Ahmad
 
Dissolution enhancement of drugs. technologies and effect of carries
Dissolution enhancement of drugs. technologies and effect of carriesDissolution enhancement of drugs. technologies and effect of carries
Dissolution enhancement of drugs. technologies and effect of carries
ferdousahmed25
 
Sublingual drug deliery system
Sublingual drug deliery systemSublingual drug deliery system
Sublingual drug deliery system
priya gupta
 
Sustained and controlled release drugs
Sustained and controlled release drugsSustained and controlled release drugs
Sustained and controlled release drugs
Aishwarya Anand
 
Presentation fACTOR AFFECTING DRUGSABSORPTION by deepak kumar
Presentation fACTOR AFFECTING DRUGSABSORPTION by deepak kumarPresentation fACTOR AFFECTING DRUGSABSORPTION by deepak kumar
Presentation fACTOR AFFECTING DRUGSABSORPTION by deepak kumar
Drx Kumar
 
Biopharmaceutical Classification System and Method to Enhance Solubility of B...
Biopharmaceutical Classification System and Method to Enhance Solubility of B...Biopharmaceutical Classification System and Method to Enhance Solubility of B...
Biopharmaceutical Classification System and Method to Enhance Solubility of B...
Sunny Kumar Sarraf
 
liquisolid system- review
liquisolid system- reviewliquisolid system- review
liquisolid system- review
vinayap95
 
Dissolution by Dr. Neeraj Mishra professor pharmaceutics
Dissolution by Dr. Neeraj Mishra professor pharmaceuticsDissolution by Dr. Neeraj Mishra professor pharmaceutics
Dissolution by Dr. Neeraj Mishra professor pharmaceutics
Neeraj Mishra
 
Techniques for enhancement of dissolution rate
Techniques for enhancement of dissolution rateTechniques for enhancement of dissolution rate
Techniques for enhancement of dissolution rate
Sagar Savale
 
Review
ReviewReview
Review
jigs2163
 
Factors affecting drug absorption
Factors affecting drug absorptionFactors affecting drug absorption
Factors affecting drug absorption
SURYAKANTVERMA2
 

Similar to Orodispersible liquisolid compacts (20)

Solid Dispersion - Solubility enhancing tool
Solid Dispersion - Solubility enhancing toolSolid Dispersion - Solubility enhancing tool
Solid Dispersion - Solubility enhancing tool
 
Formulation and Evaluation of Liquisolid Compacts of Carvedilol
Formulation and Evaluation of Liquisolid Compacts of CarvedilolFormulation and Evaluation of Liquisolid Compacts of Carvedilol
Formulation and Evaluation of Liquisolid Compacts of Carvedilol
 
Recent innovation in liquid dosage form 1by sachin
Recent innovation in liquid dosage form 1by sachinRecent innovation in liquid dosage form 1by sachin
Recent innovation in liquid dosage form 1by sachin
 
Liquisolid technology
Liquisolid technologyLiquisolid technology
Liquisolid technology
 
Pharmacokinetics mpharm
Pharmacokinetics mpharmPharmacokinetics mpharm
Pharmacokinetics mpharm
 
Controlled drug release
Controlled drug releaseControlled drug release
Controlled drug release
 
Factors affecting absorption
Factors affecting absorptionFactors affecting absorption
Factors affecting absorption
 
Factors affecting drug absorption
Factors affecting drug absorptionFactors affecting drug absorption
Factors affecting drug absorption
 
Solubility enhancement technique
Solubility enhancement technique Solubility enhancement technique
Solubility enhancement technique
 
Solubility & Method for determination of solubility
Solubility & Method for determination of solubility  Solubility & Method for determination of solubility
Solubility & Method for determination of solubility
 
Dissolution enhancement of drugs. technologies and effect of carries
Dissolution enhancement of drugs. technologies and effect of carriesDissolution enhancement of drugs. technologies and effect of carries
Dissolution enhancement of drugs. technologies and effect of carries
 
Sublingual drug deliery system
Sublingual drug deliery systemSublingual drug deliery system
Sublingual drug deliery system
 
Sustained and controlled release drugs
Sustained and controlled release drugsSustained and controlled release drugs
Sustained and controlled release drugs
 
Presentation fACTOR AFFECTING DRUGSABSORPTION by deepak kumar
Presentation fACTOR AFFECTING DRUGSABSORPTION by deepak kumarPresentation fACTOR AFFECTING DRUGSABSORPTION by deepak kumar
Presentation fACTOR AFFECTING DRUGSABSORPTION by deepak kumar
 
Biopharmaceutical Classification System and Method to Enhance Solubility of B...
Biopharmaceutical Classification System and Method to Enhance Solubility of B...Biopharmaceutical Classification System and Method to Enhance Solubility of B...
Biopharmaceutical Classification System and Method to Enhance Solubility of B...
 
liquisolid system- review
liquisolid system- reviewliquisolid system- review
liquisolid system- review
 
Dissolution by Dr. Neeraj Mishra professor pharmaceutics
Dissolution by Dr. Neeraj Mishra professor pharmaceuticsDissolution by Dr. Neeraj Mishra professor pharmaceutics
Dissolution by Dr. Neeraj Mishra professor pharmaceutics
 
Techniques for enhancement of dissolution rate
Techniques for enhancement of dissolution rateTechniques for enhancement of dissolution rate
Techniques for enhancement of dissolution rate
 
Review
ReviewReview
Review
 
Factors affecting drug absorption
Factors affecting drug absorptionFactors affecting drug absorption
Factors affecting drug absorption
 

More from Pranali Palandurkar

Gastroretentive drug delivery System
Gastroretentive drug delivery SystemGastroretentive drug delivery System
Gastroretentive drug delivery System
Pranali Palandurkar
 
Polymers
PolymersPolymers
Mucosal drug delivery system
Mucosal drug delivery systemMucosal drug delivery system
Mucosal drug delivery system
Pranali Palandurkar
 
Therapeutic goods adminstration
Therapeutic goods adminstration   Therapeutic goods adminstration
Therapeutic goods adminstration
Pranali Palandurkar
 
Ocular drug delivery system
Ocular drug delivery systemOcular drug delivery system
Ocular drug delivery system
Pranali Palandurkar
 
3 d printing of pharmaceuticals
3 d printing  of  pharmaceuticals 3 d printing  of  pharmaceuticals
3 d printing of pharmaceuticals
Pranali Palandurkar
 
Master formula record
Master formula recordMaster formula record
Master formula record
Pranali Palandurkar
 

More from Pranali Palandurkar (7)

Gastroretentive drug delivery System
Gastroretentive drug delivery SystemGastroretentive drug delivery System
Gastroretentive drug delivery System
 
Polymers
PolymersPolymers
Polymers
 
Mucosal drug delivery system
Mucosal drug delivery systemMucosal drug delivery system
Mucosal drug delivery system
 
Therapeutic goods adminstration
Therapeutic goods adminstration   Therapeutic goods adminstration
Therapeutic goods adminstration
 
Ocular drug delivery system
Ocular drug delivery systemOcular drug delivery system
Ocular drug delivery system
 
3 d printing of pharmaceuticals
3 d printing  of  pharmaceuticals 3 d printing  of  pharmaceuticals
3 d printing of pharmaceuticals
 
Master formula record
Master formula recordMaster formula record
Master formula record
 

Recently uploaded

Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
Gokuldas Hospital
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
Gokuldas Hospital
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
Donc Test
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 

Recently uploaded (20)

Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 

Orodispersible liquisolid compacts

  • 1. Orodispersible liquisolid compacts Presented by: Pranali .M.Palandurakar University department of Pharmaceutical sciences R.T.M.N.U
  • 2. INTRODUCTION  Liquisolid technique is a new and promising method which is used to enhance dissolution rate of poorly water-soluble drugs.  This new technique may be applied to formulate liquid medications into powders suitable for tableting or encapsulation.  Orodispersible formulations rapidly disintegrate and/or dissolve to release the drug as soon as they come in contact with saliva, thus without the need for water during administration .  Thus, it improves the patient’s compliance and highly attractive for pediatric and geriatric patients .
  • 3. LIQUISOLID SYSTEM:  This technique is applied to incorporate water insoluble drugs into rapid release solid dosage forms.
  • 4. COMPONENTS OF LIQUISOLID SYSTEMS  Carrier Materials: These are compression-enhancing, relatively large, preferably porous particles possessing a sufficient absorption property which contributes in liquid absorption. Ex-Various grades of cellulose, starch, lactose, sorbitol, Avicel PH 102 and 200, Eudragit RL and RS, amorphous cellulose etc.  Coating Materials: These are flow-enhancing, very fine (10 to 5,000 nm in diameter), highly adsorptive coating particles contributes in covering the wet carrier particles and displaying a dry-looking powder by adsorbing any excess liquid. Ex-Silica of various grades like Cab-O-Sil M5, Aerosil 200, Syloid 244FP etc.
  • 5.  Non-Volatile Solvents: Inert, high boiling point, preferably water- miscible and not highly viscous organic solvent systems. Ex-Polyethylene glycol 200 and 400, glycerin, polysorbate 80 and propylene glycol, polysorbates, glycerin, N, N- dimethylacetamide, fixed oils, etc.  Disintegrants: Superdisintegrants increases the rate of drug release, water solubility and wettability of liquisolid granules. Ex-Sodium starch glycolate and crosspovidone and croscarmellose sodium are used.
  • 6. MECHANISMS OF ENHANCEMENT OF DRUG RELEASE
  • 7.  Increased drug surface area  In liquisolid system the surface area of drug available for drug release is much greater than that of drug particles within directly compressed tablets because the drug present in the liquisolid system is completely dissolved in the liquid vehicle and present in the powder substrate still in a solubilized, molecularly dispersed state  In the liquid solid formulation, the release rate of the drug is directly proportional to the fraction of the molecularly dispersed drug (FM). FM= Sd/Cd Where, FM-fraction of the molecularly dispersed drug . Sd- drug solubility Cd- Actual drug concentration
  • 8.  Increased aqueous solubility of the drug In addition to the first mechanism of drug release enhancement, it is expected that the solubility of the drug might be increased with liquisolid
  • 9. Increased wettability The non-volatile solvent present in the liquisolid system provides wetting of drug particles by decreasing interfacial tension between tablet surface and dissolution medium so the contact angle of liquisolid system is lower when compared to the conventional formulation thus improved wettability .
  • 10. APPLICATIONS OF LIQUISOLID  Liquisolid compact technology is a powerful tool to improve bioavailability of water insoluble drugs. Several water insoluble drugs on dissolving in different nonvolatile solvents have been formulated into liquisolid compacts.  Different drugs can be incorporated into liquisolid compacts.  Rapid release rates.  Used for water insoluble solid drugs or liquid lipophilic drugs.  Sustained release of drugs.  Solubility and dissolution improvement.  Flowability and compressibility.  Designing of controlled release tablets.  Bioavailability enhancement.  Application in probiotics.  Improvement of drug photostability.
  • 11. ORODISPERSIBLE TABLETS  Center for Drug Evaluation and Research (CDER) defines ODT in the ‘Orange Book’ as “a solid dosage form containing medicinal substances, which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue”.
  • 12. DRUG SELECTION CRITERIA FOR ODTs The drug to be formulate as orodispersible liquisolids must have following criterias:  Drug should able to saturate the oral mucosa,  At least moderately non-ionized at oral cavity pH,  Ability to diffuse and partition into the epithelium of upper GIT,  Small to moderate molecular weight,  Low dose drugs mostly less than 50 mg,  Good stability in saliva and water,
  • 13. ADVANTAGES OF ODTs  Administration to the patients who cannot swallow, such as the elderly, stroke victims, bedridden patients, patients affected by renal failure & patients who refuse to swallow such as paediatric, geriatric & psychiatric patients gives better patient compliance  Rapid drug therapy.  Increased bioavailability/rapid absorption through pregastric absorption of drugs from mouth, pharynx & oesophagus as saliva passes down.  The risk of chocking during oral administration of conventional formulations due to physical obstruction is avoided, thus providing improved safety.  Good mouth feel property helps to change the perception of medication as bitter pill particularly in paediatric patients
  • 14. METHOD OF PREPARATION OF ORODISPERSIBLE LIQUISOLID SYSTEM Solid drugs + Non-volatile solvent Drug in solution or suspension Liquid drugs Liquid medication Wet particles Liquisolid system Final formulation Tabletting or encapsulation Carrier material Coating material Addition of other excipients or
  • 15. CHARACTERIZATION OF ORODISPERSIBLE LIQUISOLID: a) Solubility studies: Solubility studies are carried out by preparing saturated solutions of drug in non-volatile solvent and analyzing them spectrophotometrically. Saturated solutions are prepared by adding excess of drug to non volatile solvent and shaking them on shaker for specific time period under constant vibration. After this, the solutions are filtered and analyzed spectrophotometrically b) Determination of angle of slide: Angle of slide is used as a measure of the flow properties of powders. Determination of angle of slide is done by weighing the required amount of carrier material and placed at one end of a metal plate with a polished surface. The end is gradually raised till the plate becomes angular to the horizontal at which powder is about to slide. This angle is known as angle of slide. Angle of 33º is regarded as optimum
  • 16. c) Determination of flowable liquid retention potential (Φ-value): The term "flowable liquid- retention potential" (Φ-value) of a powder material describes its ability to retain a specific amount of liquid while maintaining good flow properties. The Φ-value is defined as the maximum weight of liquid that can be retained per unit weight of the powder material in order to produce an acceptably flowing liquid/powder admixture. The Φ values are calculated according to equation Φ value = weight of liquid / weight of solid d) Calculation of liquid load factor (Lf): Different concentrations of non- volatile solvents are taken and the drug is dissolved. Such liquid medication is added to the carrier-coating material admixture and blended. Drug loading factors are determined and used for calculating the amounts of carrier and coating materials in each formulation. Lf = WLM/ WCM Where: WLM is weight of liquid medication WCM is weight of carrier material.
  • 17. e) Liquisolid compressibility test (LSC): The Liquisolid compressibility test is used to determine Φ values and involves steps such as preparing carrier coating material admixture systems, preparing several uniform liquid or powder admixtures, compressing each liquid or powder admixtures to tablets, assessing the average hardness, determination of the average liquid content of crushed tablets, as well as determining plasticity, sponge index and Φ value and Lf .